Impact of diabetes on stage I lung cancer treatment patterns and prognosis in older adults: A population-based cohort study
暂无分享,去创建一个
A. Leiter | D. Leroith | C. Kong | K. Sigel | J. Wisnivesky | E. Gallagher | Jenny J. Lin | Christian Stephens | G. Mhango
[1] Eunhee Ha,et al. Association of type 2 diabetes mellitus with lung cancer in patients with chronic obstructive pulmonary disease , 2023, Frontiers in Medicine.
[2] K. Hernandez-Villafuerte,et al. Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany , 2023, Oncology research.
[3] B. Shia,et al. Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma , 2022, Cancers.
[4] Jun Zhang,et al. Targeting interleukin-1β and inflammation in lung cancer , 2022, Biomarker research.
[5] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[6] B. Seal,et al. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. , 2021, JAMA oncology.
[7] M. Ezzati,et al. Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records , 2021, The lancet. Diabetes & endocrinology.
[8] B. Stricker,et al. The Obesity Paradox in Lung Cancer: Associations With Body Size Versus Body Shape , 2020, Frontiers in Oncology.
[9] T. Okamoto,et al. Analysis of Risk Factors for Bronchopleural Fistula after Surgical Treatment of Lung Cancer , 2020, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[10] J. Leonard,et al. Diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study , 2020, Cancer.
[11] L. Xue,et al. The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis , 2019, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[12] J. Unger,et al. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation , 2019, JAMA oncology.
[13] Xi Zheng,et al. Diabetes mellitus and survival of non‐small cell lung cancer patients after surgery: A comprehensive systematic review and meta‐analysis , 2019, Thoracic cancer.
[14] A. Nicholson,et al. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. , 2018, Quantitative imaging in medicine and surgery.
[15] W. Willett,et al. Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis , 2018, Journal of the National Cancer Institute.
[16] J. I. Choi,et al. Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes. , 2018, Translational lung cancer research.
[17] M. Gould,et al. Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer , 2017, Annals of the American Thoracic Society.
[18] R. Decker,et al. Stage I Lung SBRT Clinical Practice Patterns , 2017, American journal of clinical oncology.
[19] D. Albanes,et al. Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[20] S. Jolly,et al. Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Jason D. Wright,et al. Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Isaac Subirana,et al. Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis , 2016, Diabetes Care.
[23] N. Staff,et al. Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients , 2015, Journal of the Neurological Sciences.
[24] John D. Mitchell,et al. Prediction of major cardiovascular events after lung resection using a modified scoring system. , 2014, The Annals of thoracic surgery.
[25] M. Grant,et al. Inflammation in the pathogenesis of microvascular complications in diabetes , 2012, Front. Endocrin..
[26] Andrea Bezjak,et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.
[27] E. Halm,et al. Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. , 2010, American journal of respiratory and critical care medicine.
[28] W. Katon,et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. , 2008, The American journal of managed care.
[29] J. Coebergh,et al. Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis , 2007, International journal of cancer.
[30] J. Geraci,et al. Results of General Internal Medicine Consultations for Diabetes Mellitus in 283 Cancer Patients , 2007, The American journal of the medical sciences.
[31] Edward L Spitznagel,et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Gregory S. Cooper,et al. Studying Radiation Therapy Using SEER-Medicare-Linked Data , 2002, Medical care.
[33] Beth A Virnig,et al. Utility of the SEER-Medicare Data to Identify Chemotherapy Use , 2002, Medical care.
[34] C. Klabunde,et al. Overview of the SEER-Medicare Data , 2002 .
[35] G. Cooper,et al. Use of SEER-Medicare Data for Measuring Cancer Surgery , 2002, Medical care.
[36] J L Warren,et al. Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.
[37] C. Coltman,et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.
[38] B. Yawn,et al. Identifying Persons with Diabetes Using Medicare Claims Data , 1999, American journal of medical quality : the official journal of the American College of Medical Quality.
[39] M. Mack,et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. , 1997, The Journal of thoracic and cardiovascular surgery.
[40] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.